Open J Philos 2013 Nov;3(4A):24-31
Department of Neurology, University of California, San Diego, USA.
Objective: To demonstrate challenges in the estimation of change in quality of life (QOL).
Methods: Data were taken from a completed clinical trial with negative results. Responses to 13 QOL items were obtained 12 months apart from 258 persons with Alzheimer's disease (AD) participating in a randomized, placebo-controlled clinical trial with two treatment arms. Read More